TB-500: Actin-Binding Pathway Research Overview
TB-500 is a synthetic fragment of Thymosin Beta-4 used as a research reagent in in-vitro studies of actin sequestration and cytoskeletal dynamics. The 17-residue active region binds G-actin via the conserved KLKKTET motif, providing a tractable analytical handle on actin pool availability in cellular models. As a lyophilized peptide reagent it is stable under standard storage and synthesizes cleanly at the scales typical of in-vitro research.
Actin-binding mechanism
The 17-residue active region binds G-actin via the conserved KLKKTET motif, modulating actin sequestration in cellular models. Cytoskeletal remodeling assays use TB-500 as a probe of actin pool availability, typically combined with phalloidin staining or live-cell actin reporters to visualize structural reorganization.
Because actin dynamics are highly context-dependent, matched substrate and matrix conditions across experimental runs are essential for the data to compare cleanly. Two-dimensional monolayer assays produce different readouts than three-dimensional matrix-embedded systems, and both are useful at different stages of an experimental program.
Cellular migration assays
Animal-model and in-vitro literature reports involvement in cellular migration and tissue remodeling pathway analysis. Scratch-wound and transwell migration assays are standard analytical readouts, with three-dimensional invasion assays in matrix-embedded systems forming the follow-up tier for mechanistic characterization.
TB-500 is frequently studied alongside BPC-157, because the actin-binding and angiogenic axes are complementary rather than redundant in tissue-signaling research. Co-formulated blended reagents combine the two in a single analytical input where comparative pathway dissection is the goal.
Analytical release
Analytical characterization of research-grade TB-500 typically includes HPLC purity, LC-MS identity confirmation, and residual solvent screening per ICH Q3C reference limits. The N-terminal acetyl modification is part of the active fragment and shifts both retention and mass relative to an unmodified parent sequence; analytical documentation must reflect that modification in the calculated values.
Position in the cytoskeletal-research literature
TB-500 sits within a small panel of actin-binding research peptides studied in cytoskeletal-dynamics work. As with the broader tissue-signaling literature, published findings are overwhelmingly preclinical, and analytical framing is most informative when kept strictly within the in-vitro and animal-model context that the dataset actually supports.
- [1]Goldstein, A. L. et al. Thymosin β4 and cellular migration. Ann. N. Y. Acad. Sci. (2012).